Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Free Cash Flow: 2013-2024

Historic Free Cash Flow for Surgery Partners (SGRY) over the last 11 years, with FY2024 value amounting to $209.7 million.

  • Surgery Partners' Free Cash Flow rose 4177.78% to $63.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $194.1 million, marking a year-over-year increase of 1878.82%. This contributed to the annual value of $209.7 million for FY2024, which is 229.27% up from last year.
  • As of FY2024, Surgery Partners' Free Cash Flow stood at $209.7 million, which was up 229.27% from $205.0 million recorded in FY2023.
  • Surgery Partners' 5-year Free Cash Flow high stood at $209.7 million for FY2024, and its period low was $29.5 million during FY2021.
  • Moreover, its 5-year median value for Free Cash Flow was $204.0 million (2020), whereas its average is $145.3 million.
  • Per our database at Business Quant, Surgery Partners' Free Cash Flow skyrocketed by 26493.74% in 2020 and then tumbled by 8553.92% in 2021.
  • Over the past 5 years, Surgery Partners' Free Cash Flow (Annual) stood at $204.0 million in 2020, then tumbled by 85.54% to $29.5 million in 2021, then soared by 165.08% to $78.2 million in 2022, then surged by 162.15% to $205.0 million in 2023, then rose by 2.29% to $209.7 million in 2024.
  • Its Free Cash Flow stands at $209.7 million for FY2024, versus $205.0 million for FY2023 and $78.2 million for FY2022.